Picture of Beigene logo

BGNE Beigene Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapFalling Star

Annual cashflow statement for Beigene, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUSPROSPECTUSPROSPECTUSARSARS
Standards:
CAS
CAS
CAS
CAS
CAS
Status:FinalFinalFinalFinalFinal
Changes in Working Capital-1,504-2,925-237-7,254-9,674
Other Operating Cash Flow
Cash from Operating Activities-4,200-5,546-5,180-8,285-7,800
Capital Expenditures-721-618-992-2,256-2,335
Purchase of Fixed Assets
Other Investing Cash Flow Items-3,7975,703-20,8645,3894,749
Acquisition of Business
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-4,5195,085-21,8563,1332,415
Financing Cash Flow Items10,84034729,41522,401146
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Debt
Cash from Financing Activities11,06058731,37022,867-448
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash2,4131524,24417,674-5,764